Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
[Reflections on the outcome measures in the clinical trials of multiple sclerosis].
Tolerogenic vaccines for Multiple sclerosis.
The relationship between executive functioning, processing speed, and white matter integrity in multiple sclerosis.
Measuring myeloperoxidase activity in biological samples.
The role of sphingosine 1-phosphate in immunity and sepsis.
Migraine Headaches And Pain With Neuropathic Characteristics: Comorbid Conditions In Patients With Multiple Sclerosis.
The effect of wheelchair use on the quality of life of persons with multiple sclerosis.
Aerobic intensity and pacing pattern during the six-minute walk-test in patients with multiple sclerosis.
Brain stem infarction associated with familial Mediterranean fever and central nervous system vasculitis.
Multiple sclerosis in Isfahan, Iran: an update.
Microglia-mediated neuroinflammation is an amplifier of virus-induced neuropathology.
Autoimmune Comorbidities Are Associated with Brain Injury in Multiple Sclerosis.
DENGUE WITH CENTRAL NERVOUS SYSTEM INVOLVEMENT.
Discovering Gene Regulatory Elements Using Coverage-based Heuristics.
Multiple Roles for Nogo Receptor 1 in Visual System Plasticity.
Multiple sclerosis: Generic glatiramer acetate - a step toward cheaper MS drugs?
[Demyelinating diseases in children with acute neurological symptoms].
UNUSUAL CLINICAL CASES THAT MIMIC ACUTE DISSEMINATED ENCEPHALOMYELITIS.
Multiple sclerosis at menopause: Potential neuroprotective effects of estrogen.
Semaphorin4A Is Cytotoxic to Oligodendrocytes and Is Elevated in Microglia and Multiple Sclerosis.
Acute disseminated encephalomyelitis: current knowledge and open questions.
Inflammation negatively regulates FOXP3 and regulatory T-cell function via DBC1.
Pharmacodynamics and tolerability of repository corticotropin injection in healthy human subjects: A comparison with intravenous methylprednisolone.
Aquaporin-4 antibody isoform binding specificities do not explain clinical variations in NMO.
Epstein-Barr virus infection-Related hemophagocytic lymphohistiocytosis.
Pages
« first
‹ previous
…
570
571
572
573
574
575
576
577
578
…
next ›
last »